Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Quarterly amortization rate Debt Instrument, Quarterly Amortization Rate Debt Instrument, Quarterly Amortization Rate Proceeds from employee stock purchase plan Proceeds From Employee Stock Purchase Plan Proceeds From Employee Stock Purchase Plan Weighted average amortization period Intangible Asset, Finite-Lived, Remaining Amortization Period Trading Arrangement: Trading Arrangement [Axis] Maximum Maximum [Member] Threshold number of business days before sending notice of redemption to warrant holders (in days) Class Of Warrant Or Right, Threshold Number of Business Days Before Sending Notice of Redemption to Warrant Holders Class Of Warrant Or Right, Threshold Number of Business Days Before Sending Notice of Redemption to Warrant Holders Statistical Measurement [Domain] Statistical Measurement [Domain] Title of 12(b) Security Title of 12(b) Security Subsequent event Subsequent Event [Member] Net loss attributable to common stockholders, diluted Net loss attributable to common stockholders, diluted Net Income (Loss) Available to Common Stockholders, Diluted Document Fiscal Year Focus Document Fiscal Year Focus Adjustment to Compensation, Amount Adjustment to Compensation Amount Fair value of the liability-classified medical RSU outstanding Share-based Compensation Arrangement By Share-based Payment Award, Plan Modification, Fair Value Of The Liability-classified Medical RSU Outstanding Share-based Compensation Arrangement By Share-based Payment Award, Plan Modification, Fair Value Of The Liability-classified Medical RSU Outstanding Financial Instrument [Axis] Financial Instrument [Axis] Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Conversion of stock, shares issued (in shares) Conversion of Stock, Shares Issued Customer [Axis] Customer [Axis] Segment Reporting [Abstract] Common Stock, $0.0001 par value, authorized 500,000,000 shares; 102,202,753 shares issued and 100,468,979 shares outstanding at June 30, 2026 and 100,596,918 shares issued and 98,863,144 shares outstanding at December 31, 2025 Common Stock, Value, Issued 2027 Lessee, Operating Lease, Liability, to be Paid, Year One Compensation, including bonuses, fringe benefits, and payroll taxes Employee-related Liabilities, Current Summary of Long-Term Debt, Net of Unamortized Debt Issuance Costs Schedule of Long-Term Debt Instruments [Table Text Block] Award requisite service period (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period Leases Lessee, Finance Leases [Text Block] Line of credit Line of Credit [Member] Thereafter Finance Lease, Liability, to be Paid, Thereafter Finance Lease, Liability, to be Paid, Thereafter Restatement Determination Date Restatement Determination Date Sales Agent, BTIG BTIG [Member] BTIG Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Contract with customer, asset Contract with Customer, Asset, after Allowance for Credit Loss 2027 Finance Lease, Liability, to be Paid, Year One Accrued insurance reserve Accrued Insurance, Current Derivative Instrument [Axis] Derivative Instrument [Axis] Aggregate intrinsic value of vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Aggregate Intrinsic Value, Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Aggregate Intrinsic Value, Vested Amortization period of debt issuance cost (in years) Debt Instrument, Debt Issuance Cost, Amortization Period Debt Instrument, Debt Issuance Cost, Amortization Period Number of lease modifications Lessee, Operating Lease, Number Of Leases Extended Lessee, Operating Lease, Number Of Leases Extended Net loss attributable to participating securities, basic Participating Securities, Distributed and Undistributed Earnings (Loss), Basic Number of securities called by warrants or rights (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Service allowance for doubtful accounts Accounts Receivable, Allowance for Credit Loss Debt instrument, convertible, conversion price (in dollars per share) Debt Instrument, Convertible, Conversion Price Proceeds from asset disposition Proceeds from Sale of Productive Assets Amendment Flag Amendment Flag Goodwill [Line Items] Goodwill [Line Items] Consolidated Entities [Axis] Consolidated Entities [Axis] Current liabilities: Liabilities, Current [Abstract] Other trade receivables Other Trade Receivable [Member] Represents the information pertaining to other trade receivables. Oral drug accounts receivable Oral Drug Accounts Receivable, Segment [Member] Oral Drug Accounts Receivable, Segment Clinician salaries and benefits Clinician Salaries And Benefits, Segment [Member] Clinician Salaries And Benefits, Segment Other liabilities Other Sundry Liabilities, Current Inventory [Axis] Inventory [Axis] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Principal payments on financing leases Finance Lease, Principal Payments Clinical trials & other Clinical Trials And Other, Segment [Member] Clinical Trials And Other, Segment Change in fair value of derivative warrant liabilities Change in fair value of liability classified warrants Fair Value Adjustment of Warrants Directors and officers insurance premiums Insurance Premiums, Current Insurance Premiums, Current Gross Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Goodwill Goodwill and Intangible Assets, Policy [Policy Text Block] Summary of Investment Securities Classified as Available-for-sale Debt Securities, Available-for-Sale [Table Text Block] Medical RSUs Medical Restricted Stock Units RSUs [Member] Medical Restricted Stock Units RSUs Leases [Abstract] Consolidated Entities [Domain] Consolidated Entities [Domain] Term Loan Agreement Term Loan Agreement [Member] Term Loan Agreement Component one Variable Rate Component One [Member] Variable Rate Component One Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Payor A Payor A [Member] Represents the information pertaining to Payor A. Class of warrants, common stock, exercise price percentage Class Of Warrant Or Right, Ownership Threshold Percentage Class Of Warrant Or Right, Ownership Threshold Percentage Property, Plant, and Equipment [Abstract] Entity Address, State or Province Entity Address, State or Province Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross PEO Total Compensation Amount PEO Total Compensation Amount Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Intangible assets, net Intangible Asset, Excluding Goodwill, after Accumulated Amortization Number of shares outstanding (in shares) Balance at the beginning (in shares) Balance at the end (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Capitated accounts receivable (Patient Services) Capitated Accounts Receivable [Member] Represents the information pertaining to capitated accounts receivable. Basic (in shares) Weighted average common shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Basic First anniversary of grant date Share-Based Payment Arrangement, Tranche One [Member] Accrued insurance Accrued Insurance Goodwill impairment charges Goodwill, Impaired, Accumulated Impairment Loss Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Principal exchange of convertible note for preferred stock Convertible Preferred Stock Converted to Other Securities Number of reportable segments Number of Reportable Segments Total current liabilities Liabilities, Current 2030 Lessee, Operating Lease, Liability, to be Paid, Year Four Concentration Risk [Table] Concentration Risk [Table] Capitated accounts receivable Capitated Accounts Receivable, Segment [Member] Capitated Accounts Receivable, Segment Entity Address, City or Town Entity Address, City or Town Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Share-based Compensation Arrangement by Share-based Payment Award Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Accounts Receivable Loans, Notes, Trade and Other Receivables Disclosure [Text Block] Receivables [Abstract] Statement of Financial Position [Abstract] Document Information [Line Items] Document Information [Line Items] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Class of Stock [Axis] Class of Stock [Axis] Net carrying amount Intangible Asset, Finite-Lived, after Accumulated Amortization Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net loss attributable to common stockholders, basic Net loss attributable to common stockholders, basic Net Income (Loss) Available to Common Stockholders, Basic Percentage of Net Revenue Revenue from Contract with Customer Benchmark [Member] Accumulated amortization Intangible Asset, Finite-Lived, Accumulated Amortization Level 2 Fair Value, Inputs, Level 2 [Member] Receivable [Domain] Receivable [Domain] Other non-operating expense (income) Nonoperating Income (Expense) [Abstract] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Accounts receivable, remaining amount Accounts Receivable, After Allowance for Credit Loss, Remaining Amount Accounts Receivable, After Allowance for Credit Loss, Remaining Amount Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Issuance of common stock upon vesting of RSUs (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross Intravenous (IV) drug costs Intravenous (IV) Drug Costs, Segment [Member] Intravenous (IV) Drug Costs, Segment Accrued interest Debt Instrument, Accrued Interest Debt Instrument, Accrued Interest Concentration Risk Type [Axis] Concentration Risk Type [Axis] Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Recently Issued and Adopted Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Net Loss Per Share Earnings Per Share, Policy [Policy Text Block] Summary of Financial Information for the Company's Segments Segment Reporting [Table Text Block] Loss on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Use of Estimates Use of Estimates, Policy [Policy Text Block] Amortization of debt issuance costs and debt discount Amortization of Debt Issuance Costs Related Party [Axis] Related and Nonrelated Parties [Axis] Specialty pharmacy Specialty Pharmacy [Member] Specialty Pharmacy Summary of Changes in Fair Value of Level 3 Warrant Liabilities Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Warrants price per share (in usd per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Long-term debt Long-term debt, net of unamortized debt discount and issuance costs Long-Term Debt B. Riley Securities B. Riley Securities [Member] B. Riley Securities Property and Equipment, Net Property, Plant, and Equipment [Text Block] Summary of Operating Lease Maturity Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Supplemental disclosure of noncash investing and financing activities: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Document Period End Date Document Period End Date Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Net cash and cash equivalents used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Network medical expense Network Medical Expenses [Member] Network Medical Expenses Series A preferred shares, outstanding (in shares) Balance at beginning (in shares) Balance at ending (in shares) Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Debt instrument, face amount Aggregate principal amount Debt Instrument, Face Amount 2028 Lessee, Operating Lease, Liability, to be Paid, Year Two Stockholders' Equity (Deficit) Equity [Text Block] Security Exchange Name Security Exchange Name Treasury Stock at cost, 1,733,774 shares at June 30, 2026 and December 31, 2025 Treasury Stock, Common, Value Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Pre-Funded Warrants Pre-Funded Warrants [Member] Pre-Funded Warrants Exchange Agreement, units without warrants Exchange Agreement, Units Without Warrants [Member] Exchange Agreement, Units Without Warrants Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Finance Finance Lease, Weighted Average Remaining Lease Term Entity Shell Company Entity Shell Company Consolidation Items [Domain] Consolidation Items [Domain] Change in fair value included in other expense Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Maximum total number of common shares for which stock options may be granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Current portion of operating lease liabilities Lease liabilities, current Operating Lease, Liability, Current Issuance of common stock upon exercise of warrants (in shares) Stock Issued During Period, Shares, Issued for Services Accrued interest Interest Payable, Current Due After Five Years Debt Securities, Available-For-Sale, Amortized Cost, Maturity, Allocated And Single Maturity Date, After Year 5 Debt Securities, Available-For-Sale, Amortized Cost, Maturity, Allocated And Single Maturity Date, After Year 5 Segment Reporting Segment Reporting, Policy [Policy Text Block] Summary of Property and Equipment, Net Property, Plant, and Equipment [Table Text Block] Net Loss Per Share Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Net loss per share attributable to common stockholders: Earnings Per Share [Abstract] Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Total liabilities Liabilities Trading Symbol Trading Symbol Variable Interest Entities Consolidation, Variable Interest Entity, Policy [Policy Text Block] Fair Value Debt Securities, Available-for-Sale, Excluding Accrued Interest Shares issued upon conversion (in shares) Convertible Preferred Stock, Shares Issued upon Conversion Geographical [Domain] Geographical [Domain] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Common Warrants Common Warrants [Member] Common Warrants Company Selected Measure Name Company Selected Measure Name Sale of Stock [Domain] Sale of Stock [Domain] Income Tax Disclosure [Abstract] Significant Risks and Uncertainties Including Business and Credit Concentrations Concentration Risk [Line Items] Senior Secured Convertible Note, due August 9, 2027 Total debt Aggregate principal amount Long-Term Debt, Gross Embedded Conversion Option Feature Embedded Conversion Option Feature [Member] Embedded Conversion Option Feature Common Warrants in connection with private placement and exchange agreement Common Warrants With Private Placement [Member] Common Warrants With Private Placement Credit Facility [Domain] Credit Facility [Domain] Depreciation and amortization Non-segment depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Patient services Health Care, Patient Service [Member] Noncompete agreements Noncompete Agreements [Member] Cash flows from operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Vendor A Vendor A [Member] Represents the information pertaining to Vendor A. Debt Debt, Policy [Policy Text Block] Other receivables Other Receivables, Net, Current Compensation Amount Outstanding Recovery Compensation Amount Individual: Individual [Axis] Diluted (in shares) Weighted average common shares outstanding, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Warrant Warrant [Member] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Entity Emerging Growth Company Entity Emerging Growth Company Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Useful lives Property, Plant, and Equipment, Useful Life 2028 Finance Lease, Liability, to be Paid, Year Two Underlying Security Market Price Change Underlying Security Market Price Change, Percent 2030 Finance Lease, Liability, to be Paid, Year Four Oral drug accounts receivable (Specialty Pharmacy) Oral Drug Accounts Receivable [Member] Represents the information pertaining to oral drug accounts receivable. Interest rate Accounts Payable, Interest-Bearing, Interest Rate Percentage of stock options Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Less: amount representing interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Increase in lease liability and right-of-use asset Lessee, Operating Lease, Increase In Liability And Right-Of-Use Asset Lessee, Operating Lease, Increase In Liability And Right-Of-Use Asset Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Amortization period of debt discount (in years) Debt Instrument, Convertible, Discount Amortization Period Debt Instrument, Convertible, Discount Amortization Period Other assets Increase (Decrease) in Other Noncurrent Assets Proceeds from secured lines of credit Proceeds from Secured Lines of Credit Revenue from Contract with Customer [Abstract] Clinical contracts and noncompete agreements Clinical Contracts And Noncompete Agreements [Member] Represents information pertaining to clinical contracts. Less: amount representing interest Finance Lease, Liability, Undiscounted Excess Amount Cash and Cash Equivalents Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Tax benefit from stock options exercised Share-Based Payment Arrangement, Exercise of Option, Tax Benefit Operating cash payment for operating leases Operating Lease, Payments Award Timing Predetermined Award Timing Predetermined [Flag] Treasury Stock Treasury Stock, Common [Member] Intangible Asset, Goodwill and Other [Abstract] Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Certain convertible debt lenders Certain Convertible Debt Lenders [Member] Certain Convertible Debt Lenders Share-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Level 1 Fair Value, Inputs, Level 1 [Member] Summary of Concentration Risk Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Effective income tax rate reconciliation, percent Effective Income Tax Rate Reconciliation, Percent Organization, Consolidation and Presentation of Financial Statements [Abstract] Total future lease payment Lessee, Operating Lease, Liability, to be Paid FFS revenue Fee For Service [Member] Represents the information about FFS revenue. Balance at the beginning (in dollars per share) Balance at the ending (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Inventory, Current [Table] Inventory, Current [Table] All Executive Categories All Executive Categories [Member] Number of states in which entity operates Number of States in which Entity Operates Change in operating leases Increase (Decrease) in Operating Lease Liability Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Series A preferred shares, par value (in usd per share) Preferred stock, par value (in usd per share) Preferred Stock, Par or Stated Value Per Share Depreciation expense Total segment depreciation expense Depreciation Plan Name [Domain] Plan Name [Domain] Vesting [Domain] Vesting [Domain] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Total Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost Balance at the beginning (in dollars per share) Balance at the end (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Payor C Payor C [Member] Payor C Operating right of use assets Operating Lease, Right-of-Use Asset Concentration Risk Type [Domain] Concentration Risk Type [Domain] Due in One Year or Less Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One Remaining amortization period of debt discount (in years) Debt Instrument, Debt Discount, Remaining Discount Amortization Period Debt Instrument, Debt Discount, Remaining Discount Amortization Period Summary of Basic and Diluted Net Loss Per Share to Common Stockholders Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Debt Disclosure [Abstract] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Segment Information Segment Reporting [Text Block] Cash paid for amounts included in the measurement of lease liabilities: Cash paid for amounts included in the measurement of lease liabilities [Abstract] Cash paid for amounts included in the measurement of lease liabilities [Abstract] Minimum Minimum [Member] Purchases of property and equipment included in accounts payable Purchases Of Property, Plant and Equipment Included in Accounts Payable Purchases Of Property, Plant and Equipment Included in Accounts Payable At The Market Offering At The Market Offering [Member] At The Market Offering Expiration Date Trading Arrangement Expiration Date Net increase (decrease) in cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation Liabilities Liabilities [Abstract] Number of common stock, vote per share (in votes) Common Stock, Votes Per Share Common Stock, Votes Per Share Direct costs Cost of Goods and Service Benchmark [Member] Summary of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Variable Interest Entities Variable Interest Entity Disclosure [Text Block] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Payor B Payor B [Member] Represents the information pertaining to Payor B. Summary of Estimated Aggregate Amortization Expense Intangible Asset, Finite-Lived, Amortization Expense [Table Text Block] Weighted-average number of shares outstanding: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Balance at the end (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted-Average Remaining Contractual Term Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract] Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract] Dividends, common stock Dividends, Common Stock Vested options exercisable at the end (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Gross proceeds from sale of common stock Proceeds from Issuance of Common Stock Common stock, shares authorized (in shares) Common Stock, Shares Authorized Minimum unrestricted cash and cash equivalent balance Debt Instrument, Covenant, Minimum Cash Threshold Removal Debt Instrument, Covenant, Minimum Cash Threshold Removal Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Security, Excluded EPS Calculation [Table] Significant Risks and Uncertainties Including Business and Credit Concentrations Concentration Risk Disclosure [Text Block] Expired (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Expired in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Expired in Period Number of shares issued in transaction (in shares) Sale of Stock, Number of Shares Issued in Transaction Accrued capitated leakage Accrued Capitated Leakage Accrued Capitated Leakage Accounts receivable, bad debt recovery Accounts Receivable, Allowance for Credit Loss, Recovery (Reversal) Accounts Receivable, Allowance for Credit Loss, Recovery (Reversal) Exercise Price Award Exercise Price Cash flows from investing activities: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Segment Reporting Segment Reporting [Line Items] Public and Private Warrants Public and Private Warrants [Member] Public and Private Warrants Document Quarterly Report Document Quarterly Report Convertible Note Warrant Convertible Note Warrant [Member] Convertible Note Warrant Variable Rate Component [Axis] Variable Rate Component [Axis] Variable Rate Component Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Segments [Domain] Segments [Domain] Restricted Stock Units and Restricted Stock Awards Restricted Stock Units And Restricted Stock Awards [Member] Restricted Stock Units And Restricted Stock Awards Debt Debt Disclosure [Text Block] Principal payments on long-term debt Repayments of long-term debt Repayments of Long-Term Debt Preferred stock, liquidation preference per share (in dollars per share) Preferred Stock, Liquidation Preference Per Share Debt issuance costs Less: Unamortized debt issuance costs Debt Issuance Costs, Net Supplier Concentration Supplier Concentration Risk [Member] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Other receivables Increase (Decrease) in Other Receivables Equity Component [Domain] Equity Component [Domain] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Measurement Input Type [Domain] Measurement Input Type [Domain] Term Loan Agreement Secured Debt [Member] Adoption Date Trading Arrangement Adoption Date Finance Finance Lease, Weighted Average Discount Rate, Percent Interest rate (as a percent) Debt Instrument, Interest Rate, Stated Percentage Counterparty Name [Domain] Counterparty Name [Domain] Total stockholders’ deficit Balance at beginning Balance at ending Equity, Attributable to Parent Total other non-operating expense (income) Nonoperating Income (Expense) Deferred acquisition and contingent consideration Business Combination, Consideration Transferred, Other, Current Business Combination, Consideration Transferred, Other, Current Assets Assets [Abstract] Title Trading Arrangement, Individual Title Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Term from closing of IPO Class of Warrant or Right, Exercisable, Term From Closing Of Initial Public Offering Class of Warrant or Right, Exercisable, Term From Closing Of Initial Public Offering Accounting Policies [Abstract] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Present value of future lease payment (lease liabilities) Operating Lease, Liability Conversion cap (in shares) Debt Instrument, Convertible, Conversion Cap, Shares Debt Instrument, Convertible, Conversion Cap, Shares Insider Trading Policies and Procedures [Line Items] Balance at the beginning (in shares) Balance at the end (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Present value of future lease payment (lease liabilities) Finance Lease, Liability Total segment operating income Other Operating Income Allowance for credit losses Accounts Receivable, Allowance for Credit Loss, Current Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Deferred taxes Deferred Income Tax Expense (Benefit) Selling, general and administrative expense Selling, General and Administrative Expense Private Placement Private Placement [Member] Repayment of debt Repayments of Debt Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Dividend yield Measurement Input, Expected Dividend Rate [Member] Antidilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Number of operating segments Number of Operating Segments RSUs Restricted Stock Units (RSUs) [Member] Summary of Computation of Diluted Net Loss Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Summary of Goodwill and Changes in the Carrying Amount of Goodwill Goodwill [Table Text Block] Entity Central Index Key Entity Central Index Key Less: accumulated depreciation Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization All Adjustments to Compensation All Adjustments to Compensation [Member] Proceeds from private placement, net of offering costs Proceeds from Issuance of Private Placement Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Net cash and cash equivalents provided by (used in) operating activities Net cash provided by (used in) operating Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Accounts Receivable Accounts Receivable [Member] Debt securities, available-for-sale, accrued interest, after allowance for credit loss, current, statement of financial position [Extensible Enumeration] Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Current, Statement of Financial Position [Extensible Enumeration] 2026 (remaining six months) Long-Term Debt, Maturity, Remainder of Fiscal Year Income Statement [Abstract] Stockholders’ deficit: Equity, Attributable to Parent [Abstract] Share issuances through employee stock purchase plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Document Transition Report Document Transition Report Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Operating expenses Operating Expenses [Abstract] Lease liabilities, noncurrent Finance Lease, Liability, Noncurrent Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Summary of Intangible Assets, Net Intangible Asset, Finite-Lived [Table Text Block] Total fair value of common shares vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Number of shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] City Area Code City Area Code Total future lease payment Finance Lease, Liability, to be Paid Issuance of preferred stock upon exchange of debt for equity Stock Issued During Period, Value, Conversion of Units Document Information [Table] Document Information [Table] All Individuals All Individuals [Member] Convertible note Convertible Debt Securities [Member] Subsequent events Subsequent Events [Text Block] Volatility Measurement Input, Price Volatility [Member] Debt instrument, estimated fair value Debt Instrument, Fair Value Disclosure Name Forgone Recovery, Individual Name Unrecognized compensation cost expected to be recognized over a weighted average period (in years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Supplier [Domain] Supplier [Domain] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Statement [Line Items] Statement [Line Items] Total assets Total assets Assets Operating Leases Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Cash paid for: Cash Paid For [Abstract] Cash Paid For Accounts Receivable and Allowance for Credit Losses Accounts Receivable [Policy Text Block] Series A preferred shares, shares issued (in shares) Preferred Stock, Shares Issued Thereafter Finite-Lived Intangible Asset, Expected Amortization, after Year Four Finite-Lived Intangible Asset, Expected Amortization, after Year Four Capital shares reserved for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Convertible Notes Convertible Debt [Member] Shares issued per unit held (in shares) Sale Of Stock, Shares Issued Per Unit Sale Of Stock, Shares Issued Per Unit Operating segments Operating Segments [Member] Interest expense, net Interest expense, net Interest Expense, Nonoperating Net loss attributable to participating securities, diluted Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Share-Based Compensation Share-Based Payment Arrangement [Text Block] Share issuances through employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Accrued sub-capitation Accrued Sub-Capitation, Current Accrued Sub-Capitation, Current Issuance of common stock upon private placement, net (in shares) Stock Issued During Period, Shares, New Issues PEO PEO [Member] Payor contracts Customer Contracts [Member] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense Compensation costs recognized Share-Based Payment Arrangement, Expense Other non-current liabilities Other non-current liabilities Other Liabilities, Noncurrent Goodwill Goodwill Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Issuance of common stock upon exercise of options (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Reporting Unit [Axis] Reporting Unit [Axis] Oral drug inventory Oral Drug Inventory, Segment [Member] Oral Drug Inventory, Segment Weighted-average grant date fair value (in dollars per share) Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Medical supplies and other Medical Supplies And Other, Segment [Member] Medical Supplies And Other, Segment Subsequent Event Type [Domain] Subsequent Event Type [Domain] Payables and Accruals [Abstract] Accumulated Deficit Retained Earnings [Member] Operating lease liabilities Lease liabilities, noncurrent Operating Lease, Liability, Noncurrent Money Market Fund Money Market Funds [Member] Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Summary of Assumptions used in the Valuation of Derivative Liabilities Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Changes in Stockholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Common stock, shares outstanding (in shares) Balance at beginning (in shares) Balance at ending (in shares) Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Award Timing Disclosures [Line Items] Summary of Carrying Amounts of Financial Instruments Fair Value, by Balance Sheet Grouping [Table Text Block] Diluted (in dollars per share) Net loss income per share attributable to common stockholders, diluted (in dollars per share) Earnings Per Share, Diluted Entity Current Reporting Status Entity Current Reporting Status Net cash and cash equivalents used in financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Total Shareholder Return Amount Total Shareholder Return Amount Number of equity offerings Number Of Equity Offerings Number Of Equity Offerings Expired (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Expired in Period, Weighted Average Exercise Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Expired in Period, Weighted Average Exercise Price Computers and software Computer And Software [Member] Represents the information about computers and software. Amortization expense Total segment amortization Intangible Asset, Finite-Lived, Amortization Expense Inventory [Domain] Inventory [Domain] Stockholders' Equity Note [Abstract] Intangible Asset, Finite-Lived [Line Items] Intangible Asset, Finite-Lived [Line Items] Adjustments to reconcile net loss to cash and cash equivalents used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Share-Based Payment Arrangement [Abstract] Cash flows from financing activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Total operating revenue Consolidated revenue Revenue from Contract with Customer, Excluding Assessed Tax Property and equipment, net Total property and equipment, net Property and equipment, net Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization Financial Instruments [Domain] Financial Instruments [Domain] Summary of Weighted Average Discount Rates Assets and Liabilities, Lessee [Table Text Block] Assets and Liabilities, Lessee Financial assets: Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] Inventories Inventory Disclosure [Text Block] Intangible Asset, Finite-Lived, Class [Axis] Intangible Asset, Finite-Lived, Class [Axis] Issuance of common stock upon exercise of options Stock Issued During Period, Value, Stock Options Exercised Number of monthly installments Number Of Instalments Payable Number Of Instalments Payable Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Goodwill and Intangible Assets Intangible Asset and Goodwill [Text Block] Underlying Securities Award Underlying Securities Amount Revenue Revenue from Contract with Customer [Text Block] Issuance of common stock upon private placement, net Stock Issued During Period, Value, New Issues Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Preferred Stock Preferred Stock [Member] Construction in progress Construction in Progress [Member] Inventories Increase (Decrease) in Inventories Operating Operating Lease, Weighted Average Discount Rate, Percent Summary of the Activity for the RSUs and RSAs Nonvested Restricted Stock Shares Activity [Table Text Block] Segment Reporting [Table] Segment Reporting [Table] Summary of Maturities of Long-Term Debt Schedule of Maturities of Long-Term Debt [Table Text Block] Sale of Stock [Axis] Sale of Stock [Axis] Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Weighted average remaining contractual term (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Summary of Lease, Cost Lease, Cost [Table Text Block] Accrued Expenses and Other Current Liabilities Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Patient services Patient Services, Segment [Member] Patient Services, Segment Commitments and Contingencies Disclosure [Abstract] All Trading Arrangements All Trading Arrangements [Member] Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Change in fair value of conversion option derivative liabilities Change in fair value of liability classified conversion option derivatives Derivative, Gain (Loss) on Derivative, Net Other Performance Measure, Amount Other Performance Measure, Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Loss from operations Operating Income (Loss) Current Fiscal Year End Date Current Fiscal Year End Date Summary of Finance Lease Maturity Finance Lease, Liability, to be Paid, Maturity [Table Text Block] 2026 (remaining six months) Finance Lease, Liability, to be Paid, Remainder of Fiscal Year Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Entity File Number Entity File Number Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Optional Redemption Optional Redemption [Member] Optional Redemption Variable Rate Component [Domain] Variable Rate Component [Domain] Variable Rate Component [Domain] Summary of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Weighted average exercise price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Basic and diluted net income (loss) per share of common stock: Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Common stock, shares issued (in shares) Common Stock, Shares, Issued Measure: Measure [Axis] Summary of Consolidated Financial Statements of VIEs Schedule of Variable Interest Entities [Table Text Block] Description of the Business Business Description and Basis of Presentation [Text Block] Write-off of assets from clinical trials segment Loss on sale due to the write-off Segment Assets Written-Off Segment Assets Written-Off Treasury stock (in shares) Treasury Stock, Common, Shares Direct costs Total segment direct costs Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization Equity Components [Axis] Equity Components [Axis] Accounts receivable Increase (Decrease) in Accounts Receivable Related party Related Party [Member] Product and Service [Domain] Product and Service [Domain] Common and Preferred Shares Class of Stock [Line Items] Income taxes Income Tax Paid, after Refund Received California CALIFORNIA Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Common Class A Common Class A [Member] Entity Interactive Data Current Entity Interactive Data Current Lease liabilities, current Finance Lease, Liability, Current Variable Interest Entities Variable Interest Entity [Line Items] Supplier Finance Program [Line Items] Supplier Finance Program [Line Items] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Due After One Year through Five Years Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five Issuance of preferred stock upon exchange of debt for equity (in shares) Stock Issued During Period, Shares, Conversion of Units Entity Small Business Entity Small Business Less: Unamortized debt discount Debt Instrument, Unamortized Discount 2029 Lessee, Operating Lease, Liability, to be Paid, Year Three Termination Date Trading Arrangement Termination Date Property and Equipment, Net Property, Plant, and Equipment [Line Items] Capitated revenue Capitated Revenue [Member] Represents the information about capitated revenue. Subsequent Events [Abstract] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Interest accrued Debt Instrument, Increase, Accrued Interest Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Total accrued expenses and other current liabilities Amounts due to affiliates Other Liabilities, Current Term of award (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Other assets Other Assets, Noncurrent 2029 Finance Lease, Liability, to be Paid, Year Three Document Type Document Type Finance lease ROU assets Finance Lease ROU Assets [Member] Finance Lease ROU Assets [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Gain (loss) on extinguishment of debt Gain (Loss) on Extinguishment of Debt Accrued expenses and other current liabilities Accrued Liabilities, Current Fair Value as of Grant Date Award Grant Date Fair Value Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Goodwill [Table] Goodwill [Table] Vested options exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Total operating expenses Operating Costs and Expenses Arrangement Duration Trading Arrangement Duration Subsequent Event [Line Items] Subsequent Event [Line Items] Statement of Stockholders' Equity [Abstract] Local Phone Number Local Phone Number Other assets Other Assets, Segment [Member] Other Assets, Segment Consolidation Items [Axis] Consolidation Items [Axis] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Registrant Name Entity Registrant Name Warrants price per share (in usd per share) Class Of Warrant Or Right, Redemption Price Of Warrants Or Rights Class Of Warrant Or Right, Redemption Price Of Warrants Or Rights Loss before provision for income taxes Consolidated loss before provision for income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Warrants term (in years) Warrants and Rights Outstanding, Term Commitments and contingencies (Note 15) Commitments and Contingencies Gross carrying amount Intangible Asset, Finite-Lived, before Accumulated Amortization Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Property and equipment, gross Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] 2030 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Four Facility Agreement Facility Agreement [Member] Facility Agreement FFS accounts receivable FFS Accounts Receivable, Segment [Member] FFS Accounts Receivable, Segment Thereafter Lessee, Operating Lease, Liability, to be Paid, Thereafter Lessee, Operating Lease, Liability, to be Paid, Thereafter Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Executive Category: Executive Category [Axis] Amortization of ROU asset Finance Lease, Right-of-Use Asset, Amortization Receivable Type [Axis] Receivable Type [Axis] Counterparty Name [Axis] Counterparty Name [Axis] Office furniture Furniture and Fixtures [Member] Unit price Measurement Input, Unit Price [Member] Measurement Input, Unit Price Liabilities and stockholders’ deficit Liabilities and Equity [Abstract] Intangible Asset, Finite-Lived, Class [Domain] Intangible Asset, Finite-Lived, Class [Domain] Vested options exercisable at the end (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted-Average Remaining Contractual Term Minimum number of oncologists and mid-level professionals within three states Number Of Oncologists And Mid-Level Professionals Within Three States, Minimum Represents the minimum number of oncologists and mid-level professionals within three states. Trade names Trade Names [Member] Inventories Total Inventories Inventory, Net Award Type [Domain] Award Type [Domain] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Interest expense Finance Lease, Interest Expense Number of warrants outstanding (in shares) Class of Warrant or Right, Outstanding 2026 (remaining six months) Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Marketable Securities and Fair Value Measurements Fair Value Disclosures [Text Block] Variable Interest Entity [Table] Variable Interest Entity [Table] Level 3 Fair Value, Inputs, Level 3 [Member] Supplemental disclosure of cash flow information: Supplemental cash flow information Supplemental Cash Flow Information [Abstract] 2027 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year One Component two Variable Rate Component Two [Member] Variable Rate Component Two Operating lease term (in years) Lessee, Operating Lease, Term of Contract PEO Name PEO Name Derivative Liabilities Derivative Instrument [Member] Derivative Instrument Right-of-use assets in connection with operating lease modifications Right-Of-Use Assets In Connection With Operating Lease Modifications Right-Of-Use Assets In Connection With Operating Lease Modifications Geographical [Axis] Geographical [Axis] Accrued expenses and other current liabilities Increase (Decrease) in Accrued Liabilities Leasehold improvements Leasehold Improvements [Member] Contract liabilities Contract with Customer, Liability Financial liabilities: Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract] Long-Lived Asset, Class [Axis] Long-Lived Asset, Class [Axis] Financed insurance premiums Non-Cash, Financed Insurance Premiums Non-Cash, Financed Insurance Premiums Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Entity Tax Identification Number Entity Tax Identification Number Liability Class [Axis] Liability Class [Axis] Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Intangible Asset, Finite-Lived [Table] Intangible Asset, Finite-Lived [Table] Accounts payable Increase (Decrease) in Accounts Payable Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Operating leases Right-Of-Use Asset Obtained In Exchange For Operating Lease Liability, Net Right-Of-Use Asset Obtained In Exchange For Operating Lease Liability, Net Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] RSUs and RSAs Restricted Stock Units And Awards [Member] Restricted Stock Units And Awards Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Non-NEOs Non-NEOs [Member] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Debt Instrument [Axis] Debt Instrument [Axis] Subsequent Event [Table] Subsequent Event [Table] Reporting Unit [Domain] Reporting Unit [Domain] Share-based compensation Share-Based Payment Arrangement, Noncash Expense 2028 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Two Purchase price of common stock, percent Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Financing cash payments for finance leases Repayments for Finance Lease Repayments for Finance Lease Conversion of preferred stock to common stock (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Customer [Domain] Customer [Domain] Summary of Inventories Schedule of Inventory, Current [Table Text Block] Leases Lessee, Operating Leases [Text Block] 2027 Long-Term Debt, Maturity, Year One Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Basic (in dollars per share) Net loss income per share attributable to common stockholders, basic (in dollars per share) Earnings Per Share, Basic Vendor B Vendor B [Member] Vendor B Measurement Input Type [Axis] Measurement Input Type [Axis] Risk-free rate Measurement Input, Risk Free Interest Rate [Member] Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Insider Trading Arrangements [Line Items] Supplier Finance Program [Table] Supplier Finance Program [Table] Long-term debt, net of unamortized debt issuance costs Long-Term Debt, Excluding Current Maturities Award Type [Axis] Award Type [Axis] Short-term lease costs Short-Term Lease, Cost Private Warrants Private Warrants [Member] Private Warrants Weighted-average discount rate Weighted-Average Discount Rate [Abstract] Weighted-Average Discount Rate Repayments on advances Repayments On Advances Repayments On Advances Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss Accounts receivable, net Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Gross payables Accounts Payable [Member] Accumulated deficit Retained Earnings (Accumulated Deficit) Derivative warrant liabilities Derivative warrant liabilities Derivative Warrant Liabilities, Noncurrent Derivative Warrant Liabilities, Noncurrent Florida FLORIDA Product and Service [Axis] Product and Service [Axis] Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Common Stock Common Stock Common Stock [Member] Operating lease costs: Operating Lease, Cost Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Shares issued in period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period Cost of equity Measurement Input, Cost Of Equity [Member] Measurement Input, Cost Of Equity Cover [Abstract] Public Warrants Public Warrants [Member] Represents information pertaining to public warrants. Maximum percent of common stock allowed Preferred Stock, Maximum Percent of Common Stock Allowed Preferred Stock, Maximum Percent of Common Stock Allowed Year ending December 31: Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity [Abstract] Derivative Contract [Domain] Derivative Contract [Domain] Concentration risk percentage Concentration Risk, Percentage Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Equity Awards Adjustments Equity Awards Adjustments [Member] FFS accounts receivable, net (Patient Services) Ffs Accounts Receivable [Member] Represents the information pertaining to FFS accounts receivable. Payments made for financing of insurance payments Payments For Financing Of Insurance Payments Payments For Financing Of Insurance Payments Total liabilities and stockholders’ deficit Liabilities and Equity Derivative liabilities Optional redemption derivative liabilities Derivative Liability, Noncurrent Variable lease costs Variable Lease, Cost Stock options Share-Based Payment Arrangement, Option [Member] Segments [Axis] Segments [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Related Party [Domain] Related and Nonrelated Parties [Domain] Plan Name [Axis] Plan Name [Axis] Summary of Accounts Receivable Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Fair value measurements inputs Derivative Liability, Measurement Input Inventory Disclosure [Abstract] Tabular List, Table Tabular List [Table Text Block] Vesting [Axis] Vesting [Axis] Additional paid-in capital Additional Paid in Capital Intangible Asset, Finite-Lived, after Accumulated Amortization [Abstract] Intangible Asset, Finite-Lived, after Accumulated Amortization [Abstract] Other non-current liabilities Increase (Decrease) in Other Noncurrent Liabilities Other, net Other, net Other Nonoperating Income (Expense) Warrant redemption maximum common share price (in dollars per share) Class Of Warrant Or Right, Warrant Redemption Condition, Maximum Common Share Price Class Of Warrant Or Right, Warrant Redemption Condition, Maximum Common Share Price 2029 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Three 2026 (remaining six months) Intangible Asset, Finite-Lived, Estimated Amortization Expense, Remainder of Fiscal Year Name Awards Close in Time to MNPI Disclosures, Individual Name Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Aggregate intrinsic value (in thousands) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Summary of Accrued Expenses and Other Current Liabilities Other Current Liabilities [Table Text Block] Long-Lived Asset, Class [Domain] Long-Lived Asset, Class [Domain] Sale of stock, price (in dollars per share) Sale of Stock, Price Per Share Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Series A preferred shares, authorized (in shares) Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Property, Plant, and Equipment [Table] Property, Plant, and Equipment [Table] Specialty Pharmacy Specialty pharmacy revenue Health Care, Specialty Pharmacy [Member] Health Care, Specialty Pharmacy Series A Convertible Preferred Stock, $0.0001 par value, authorized 10,000,000 shares; 193,507 shares issued and outstanding at June 30, 2026 and December 31, 2025 Preferred Stock, Value, Issued Adjustment to Compensation: Adjustment to Compensation [Axis] Derivative Liabilities Derivative Financial Instruments, Liabilities [Member] Class of Stock [Domain] Class of Stock [Domain] Supplier [Axis] Supplier [Axis] Minimum number of clinic locations within three states Number Of Clinic Locations Number Of Clinic Locations Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Interest Interest Paid, Excluding Capitalized Interest, Operating Activity Statement of Cash Flows [Abstract] Inventory [Line Items] Inventory [Line Items] Credit Facility [Axis] Credit Facility [Axis] Exchange agreement warrants acquired in agreement (in shares) Common Stock, Convertible, Shares Issuable Common Stock, Convertible, Shares Issuable Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Investments in Marketable Securities Investment, Policy [Policy Text Block] Financing arrangement Accounts Payable Name Measure Name Income Taxes Income Tax Disclosure [Text Block] Accounts payable Accounts payable Accounts Payable, Current Pay vs Performance Disclosure [Line Items] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Debt Instrument [Line Items] Debt Instrument [Line Items] Entity Information, Former Legal or Registered Name Entity Information, Former Legal or Registered Name Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Threshold trading days (in days) Class Of Warrant Or Right, Redemption Of Warrants Or Rights, Threshold Trading Days Class Of Warrant Or Right, Redemption Of Warrants Or Rights, Threshold Trading Days Additional Paid in Capital Additional Paid-in Capital [Member] Entity Filer Category Entity Filer Category Medical equipment Equipment [Member] Goodwill impairment charges Goodwill, Impairment Loss IV drug inventory IV Drug Inventory, Segment [Member] IV Drug Inventory, Segment IV drug inventory Iv Drug Inventory [Member] Represents the information about IV drug inventory. Name Trading Arrangement, Individual Name Unrecognized compensation expense Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Term (in years) Measurement Input, Expected Term [Member] Effective yield (as a percent) Debt Instrument, Interest Rate During Period Weighted-average remaining lease term (in years) Weighted-Average Remaining Lease Term [Abstract] Weighted-Average Remaining Lease Term Finance Leases Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Minimum net quarterly revenues Debt Instrument, Covenant, Minimum Net Quarterly Revenues Debt Instrument, Covenant, Minimum Net Quarterly Revenues Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Company Selected Measure Amount Company Selected Measure Amount Depreciation and amortization Depreciation, Depletion and Amortization Net loss attributable to Starling available for distribution Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic Employee Stock Purchase Plan Employee Stock Purchase Plan [Member] Employee Stock Purchase Plan 2021 Plan Two Thousand And Twenty One Plan [Member] Two Thousand And Twenty One Plan Stock, Class of Stock [Table] Stock, Class of Stock [Table] Accounts and Financing Receivables [Table] Accounts and Financing Receivables [Table] Current assets: Assets, Current [Abstract] Operating Operating Lease, Weighted Average Remaining Lease Term Non-PEO NEO Non-PEO NEO [Member] Entity Address, Address Line One Entity Address, Address Line One Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Income tax benefit (expense) Income tax expense (benefit) Income Tax Expense (Benefit) Comprehensive Loss Comprehensive Income, Policy [Policy Text Block] Risks and Uncertainties [Abstract] Customer concentration Customer Concentration Risk [Member] Award Timing Method Award Timing Method [Text Block] Principles of Consolidation Consolidation, Policy [Policy Text Block] Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Variable interest entity Variable Interest Entity, Primary Beneficiary [Member] Net loss Net loss Net loss Net loss attributable to Starling Net Income (Loss) Attributable to Parent Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Statement [Table] Statement [Table] Minimum net revenue Debt Instrument, Covenant, Minimum Net Revenue Debt Instrument, Covenant, Minimum Net Revenue Items not allocated to segments Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment [Member] Equal monthly-basis vesting through fourth anniversary of grant date Share-Based Payment Arrangement, Tranche Two [Member] Oral drug inventory Oral Drug Inventory [Member] Represents the information about Oral drug inventory. Clinical trials & other Clinical research trials and other revenue Clinical Research Trials And Other Revenue [Member] Represents the information pertaining to Clinical trials & other. Specialty pharmacy Specialty Pharmacy, Segment [Member] Specialty Pharmacy, Segment Restatement Determination Date: Restatement Determination Date [Axis] Number of securities called by each warrant (in shares) Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Common stock issued for options exercised Proceeds from Stock Options Exercised Exchange agreement, principal amount of debt exchanged for securities (in shares) Debt Conversion, Converted Instrument, Amount Vested options exercisable at the end (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Threshold consecutive trading days (in days) Class Of Warrant Or Right, Redemption Of Warrants Or Rights, Threshold Consecutive Trading Days Class Of Warrant Or Right, Redemption Of Warrants Or Rights, Threshold Consecutive Trading Days Minimum threshold written notice period for redemption of public warrants Class of Warrant Or Right, Redemption Period, Written Notice Class of Warrant Or Right, Redemption Period, Written Notice Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Accrued interest receivable on cash equivalents and marketable securities Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Current Revenue Revenues [Abstract] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block]